Go Pro

KraneShares MSCI All China Health Care Index ETF (KURE) Holdings List

$16.46 0.00 (0.00%)
As of 07/2/2026 04:10 PM Eastern

What stocks does KURE hold?

The KraneShares MSCI All China Health Care Index ETF (KURE) top stock holdings include BeOne Medicines AG, Innovent Biologics, Inc., and WuXi Biologics (Cayman) Inc.. The top 25 KURE holdings ordered by weight make up 82.61% of the total fund. KURE is an equity fund in the sector category that invests in publicly traded companies and other investments, focused on health care strategies within the Asia-Pacific region. This page includes a complete KURE stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 KURE Holdings

RankCompanyCurrent PriceWeightShares Held
1BeOne Medicines AGN/A9.05%297,918
2Innovent Biologics, Inc.N/A8.57%593,500
3WuXi Biologics (Cayman) Inc.N/A7.78%1,322,635
4WuXi AppTec Co., Ltd.N/A6.43%277,720
5Jiangsu Hengrui Pharmaceuticals Co.,LtdN/A4.63%433,708
6Shenzhen Mindray Bio-Medical Electronics Co., Ltd.N/A4.34%142,855
7
WuXi AppTec Co., Ltd. stock logo
WUXIF
WuXi AppTec
$21.19
3.80%153,684
8CSPC Pharmaceutical Group LimitedN/A3.76%2,908,889
9Akeso, Inc.N/A3.71%230,000
10Sino Biopharmaceutical LimitedN/A3.40%4,078,750
11Hansoh Pharmaceutical Group Company LimitedN/A2.86%512,000
123SBio Inc.N/A2.45%788,500
13Yunnan Baiyao Group Co.,LtdN/A2.35%221,723
14Shanghai United Imaging Healthcare Co., Ltd.N/A2.29%102,398
15Aier Eye Hospital Group Co., Ltd.N/A2.17%1,158,663
16Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.N/A1.85%75,034
17Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.N/A1.73%23,000
18Sichuan Biokin Pharmaceutical Co.,Ltd.N/A1.69%30,792
19Sinopharm Group Co. Ltd.N/A1.64%556,400
20Sichuan Kelun Pharmaceutical Co., Ltd.N/A1.61%198,515
21Huadong Medicine Co., LtdN/A1.37%217,941
22WuXi XDC Cayman Inc.N/A1.32%143,500
23Shanghai Fosun Pharmaceutical (Group) Co., Ltd.N/A1.28%263,229
24
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
$29.91
1.27%29,380
25Haisco Pharmaceutical Group Co., Ltd.N/A1.26%109,000

KURE Geographic Exposure

KURE's largest geographic exposure is China at 40.0%, followed by Cayman Islands at 23.5%.

  • China
    40.0%
  • Cayman Islands
    23.5%
  • Hong Kong
    11.4%
  • United States
    1.3%

KURE Currency Exposure

KURE's largest currency exposure is HKD at 36.6%, followed by CNY at 28.5%.

  • HKD
    36.6%
  • CNY
    28.5%

KURE Sector Exposure

KURE's largest sector exposure is Health Care at 89.1%, followed by Real Estate at 1.1%.

  • Health Care
    89.1%
  • Real Estate
    1.1%
  • Consumer Staples
    0.9%

KURE Industry Exposure

KURE's largest industry exposure is Biotechnology at 53.3%, followed by Life Sciences Tools & Services at 12.3%.

  • Biotechnology
    53.3%
  • Life Sciences Tools & Services
    12.3%
  • Health Care Equipment & Supplies
    8.3%
  • Pharmaceuticals
    8.1%
  • Health Care Technology
    2.8%
  • Health Care Equipment & Suppli
    2.2%
  • Health Care Providers & Services
    2.0%
  • Diversified REITs
    1.1%
  • Food Products
    0.9%

KURE Sub-Industry Exposure

KURE's largest sub-industry exposure is Biotechnology at 49.5%, followed by Life Sciences Tools & Services at 12.3%.

  • Biotechnology
    49.5%
  • Life Sciences Tools & Services
    12.3%
  • Pharmaceuticals
    9.9%
  • Health Care Equipment
    8.7%
  • Health Care Distributors
    2.8%
  • Health Care Services
    2.0%
  • Diversified REITs
    1.1%
  • Packaged Foods & Meats
    0.9%
  • Health Care Supplies
    0.1%

Related Companies and Tools


This page (NYSEARCA:KURE) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners